Osteoinductive molecules in orthopaedics: Basic science and preclinical studies

Clinical Orthopaedics and Related Research

Volumn 395, Issue , 2002, Pages 33-43

  Yoon, S Tim ^a   Boden, Scott D ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; BONE MORPHOGENETIC PROTEIN; CYTOKINE; FIBROBLAST GROWTH FACTOR; GROWTH DIFFERENTIATION FACTOR 5; GROWTH FACTOR; LIM MINERALIZATION PROTEIN 1; NEOSTEO; PEPTIDE; PLATELET DERIVED GROWTH FACTOR; POLYGLACTIN; SOMATOMEDIN; SYNAPSIN I; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; BONE DEVELOPMENT; BONE MATRIX; CELL COMMUNICATION; CONFERENCE PAPER; DOSE RESPONSE; DRUG FORMULATION; GENE THERAPY; IMPLANT; NONHUMAN; ORTHOPEDIC SURGERY; OSSIFICATION; PRIORITY JOURNAL; RAT; SPINE FUSION; SPINE RADIOGRAPHY;

EID: 0036166392     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-200202000-00005     Document Type: Conference Paper

References (59)

1. Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapy
2. A recombinant human TGF-beta1 fusion protein with collagen-binding domain promotes migration, growth, and differentiation of bone marrow mesenchymal cells
3. Tibial segmental defect repair: Chondrogenesis and biomechanical strength modulated by basic fibroblast growth factor
4. Gene therapy for spine fusion
5. LMP-1, A LIM-domain protein, mediates BMP-6 effects on bone formation
6. The use of coralline hydroxyapatite with bone marrow, autogenous bone graft, or osteoinductive bone protein extract for posterolateral lumbar spine fusion
7. Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage
8. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate
9. Video-assisted lateral intertransverse process arthrodesis. Validation of a new minimally invasive lumbar spinal fusion technique in the rabbit and nonhuman primate (rhesus) models
10. Lumbar spine fusion by local gene therapy with a cDNA encoding a novel osteoinductive protein (LMP-1)
11. Bone morphogenetic protein 2 (BMP-2) enhances BMP-3, BMP-4, and bone cell differentiation marker gene expression during the induction of mineralized bone matrix formation in cultures of fetal rat calvarial osteoblasts
12. In vivo evaluation of recombinant human osteogenic protein (rhOP-1) implants as a bone graft substitute for spinal fusions
13. Osteogenic protein versus autologous interbody arthrodesis in the sheep thoracic spine: A comparative endoscopic study using the Bagby and Kuslich interbody fusion device
14. The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes
15. Demineralized bone matrix: Enhancement of spinal fusion
16. Insulin-like growth factor II promoter expression in cultured rodent osteoblasts and adult rat bone
17. The use of recombinant human bone morphogenetic protein 2 (rhBMP-2) to promote spinal fusion in a non-human primate anterior interbody fusion model
18. Bone morphogenetic protein but not transforming growth factor-beta enhances bone formation in canine diaphyseal nonunions implanted with a biodegradable composite polymer
19. Analysis of limb patterning in BMP-7-deficient mice
20. Morphology of the lumbar intertransverse process fusion mass in the rabbit model: A comparison between two bone graft materials - rhBMP-2 and autograft
21. Osteogenic protein-1 stimulates mRNA levels of BMP-6 and decreases mRNA levels of BMP-2 and -4 in human osteosarcoma cells
22. Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo
23. Continuous administration of basic fibroblast growth factor (FGF-2) accelerates bone induction on rat calvaria: An application of a new drug delivery system
24. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats
25. Regional gene therapy with a BMP-2-producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents
26. Response of bone marrow stroma cells to demineralized cortical bone matrix in experimental spinal fusion in rabbits
27. Gene therapy: Adenovirus-mediated human bone morphogenetic protein-2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo
28. Augmentation of spinal fusion with bone morphogenetic protein in dogs
29. Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion
30. New formulations of demineralized bone matrix as a more effective graft alternative in experimental posterolateral lumbar spine arthrodesis
31. Subtle differences in the mitogenic effects of recombinant human bone morphogenetic proteins-2 to -7 on DNA synthesis on primary bone-forming cells and identification of BMP-2/4 receptor
32. Positive and negative regulation of TGF-beta signaling
33. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation
34. Demineralized bone matrix as a graft extender in posterolateral lumbar spine arthrodesis
35. Experimental posterolateral lumbar spinal fusion with a demineralized bone matrix gel
36. Gene expression during autograft lumbar spine fusion and the effect of bone morphogenetic protein-2
37. Evaluation of human bone morphogenetic protein 2 in a canine spinal fusion model
38. Stimulation of bone formation by recombinant fibroblast growth factor-2 in callotasis bone lengthening of rabbits
39. Novel formulation of fibroblast growth factor-2 in a hyaluronan gel accelerates fracture healing in non-human primates
40. Interaction of allogeneic demineralized bone matrix and porous hydroxyapatite bioceramics in lumbar interbody fusion in rabbits
41. Bone morphogenetic protein-2: Biology and applications
42. Evaluation of rhBMP-2 with an OPLA carrier in a canine posterolateral (transverse process) spinal fusion model
43. Effective doses of recombinant bone morphogenetic protein-2 in experimental spinal fusion
44. Experimental spinal fusion with recombinant human bone morphogenetic protein-2
45. Reversing the inhibitory effect of nicotine on spinal fusion using an osteoinductive protein extract
46. Mice lacking BMP 6 function
47. Inductive activity of recombinant human growth and differentiation factor-5
48. Limb alterations in brachypodism mice due to mutations in a new member of the TGF beta-superfamily
49. The role of bone marrow in bone morphogenetic protein induced repair of femoral massive diaphyseal defects
50. Effect of insulin-like growth factor type 1 on critical-size defects in diabetic rats
51. Effect of insulin-like growth factor type I on critical size calvarial bone defects in irradiated rats
52. Mandibular reconstruction with a recombinant bone-inducing factor: Functional, histologic, and biomechanical evaluation
53. Repair of a rodent nasal critical-size osseous defect with osteoblast augmented collagen gel
54. Bone formation by autoinduction
55. Bone cell differentiation and growth factors
56. Adenoviral delivery of LIM mineralization protein-1 induces new-bone formation in vitro and in vivo
57. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2): A radiographic, histological, and biomechanical study in rats
58. Cervical interbody fusion cages: An animal model with and without bone morphogenetic protein
59. Effects of recombinant human fibroblast growth factor-2 on osteogenic cell populations during orthopic osteogenesis in vivo